Active	Status	Sponsor type	Region	Phase	Filter
12 Active 7 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Haddad, Elie
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation	Active, not recruiting	4	3000	US	Dronedarone, Multaq	American Heart Association, Duke Clinical Research Institute, Sanofi	Atrial Fibrillation	06/24	12/24
SURPASS-EARLY, NCT05433584: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes	Active, not recruiting	4	780	Europe, Canada, US, RoW	Tirzepatide, LY3298176, Antihyperglycemic medication	Eli Lilly and Company	Type 2 Diabetes	10/25	11/27
NCT06037252: A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity	Recruiting	2	350	US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Type 2 Diabetes, Obesity	01/26	10/26
NCT02926404 / 2014-005553-39: UNiD Rods Register	Terminated	N/A	743	Europe	UNiD Rods, Patient Specific Rods	Medicrea International	Idiopathic Scoliosis, Spinal Curvatures, Spondylolisthesis, Degenerative Scoliosis	10/22	10/22
Frangoul, Haydar
No trials found